Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Natalia E. Moskaleva"'
Autor:
Sergey Girel, Pavel A. Markin, Elena Tobolkina, Julien Boccard, Natalia E. Moskaleva, Serge Rudaz, Svetlana A. Appolonova
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The steroid submetabolome, or steroidome, is of particular interest in prostate cancer (PCa) as the dependence of PCa growth on androgens is well known and has been routinely exploited in treatment for decades. Nevertheless, the community is
Externí odkaz:
https://doaj.org/article/321e2f0df9584834938de30f327ef8cf
Autor:
Iosif B. Mikhel, Elena O. Bakhrushina, Danila A. Petrusevich, Andrey A. Nedorubov, Svetlana A. Appolonova, Natalia E. Moskaleva, Natalia B. Demina, Svetlana I. Kosenkova, Mikhail A. Parshenkov, Ivan I. Krasnyuk
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1125 (2024)
Recently, ribavirin has demonstrated effectiveness in treating glioblastoma through intranasal administration utilizing the nose-to-brain delivery route. Enhancing ribavirin’s bioavailability can be achieved by utilizing intranasal stimuli-responsi
Externí odkaz:
https://doaj.org/article/21faad652b6d403e958ace4327e26340
Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer
Autor:
Ksenia M. Shestakova, Natalia E. Moskaleva, Andrey A. Boldin, Pavel M. Rezvanov, Alexandr V. Shestopalov, Sergey A. Rumyantsev, Elena Yu. Zlatnik, Inna A. Novikova, Alexander B. Sagakyants, Sofya V. Timofeeva, Yuriy Simonov, Sabina N. Baskhanova, Elena Tobolkina, Serge Rudaz, Svetlana A. Appolonova
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Lung cancer is referred to as the second most common cancer worldwide and is mainly associated with complex diagnostics and the absence of personalized therapy. Metabolomics may provide significant insights into the improvement of lung cance
Externí odkaz:
https://doaj.org/article/aaab72de8a6349c2873076e710e43142
Autor:
Yuri N. Belenkov, Anton A. Ageev, Maria V. Kozhevnikova, Natalia V. Khabarova, Anastasia V. Krivova, Ekaterina O. Korobkova, Ludmila V. Popova, Alexey V. Emelyanov, Svetlana A. Appolonova, Natalia E. Moskaleva, Ksenia M. Shestakova, Elena V. Privalova
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 10, p 438 (2023)
Background: Progressive myocardial remodeling (MR) in chronic heart failure (CHF) leads to aggravation of systolic dysfunction (SD) and clinical manifestations. Identification of metabolomic markers of these processes may help in the search for new t
Externí odkaz:
https://doaj.org/article/c673383692a64fe28a764eec466c4fee
Autor:
Natalia E. Moskaleva, Ksenia M. Shestakova, Alexey V. Kukharenko, Pavel A. Markin, Maria V. Kozhevnikova, Ekaterina O. Korobkova, Alex Brito, Sabina N. Baskhanova, Natalia V. Mesonzhnik, Yuri N. Belenkov, Natalia V. Pyatigorskaya, Elena Tobolkina, Serge Rudaz, Svetlana A. Appolonova
Publikováno v:
Metabolites, Vol 12, Iss 12, p 1185 (2022)
Metabolomics is a promising technology for the application of translational medicine to cardiovascular risk. Here, we applied a liquid chromatography/tandem mass spectrometry approach to explore the associations between plasma concentrations of amino
Externí odkaz:
https://doaj.org/article/0fa854bc4ef940a3ac580963c35b98a7
Autor:
Ksenia M. Shestakova, Natalia V. Mesonzhnik, Pavel A. Markin, Natalia E. Moskaleva, Andrey A. Nedorubov, Alex Brito, Elizaveta G. Appolonova, Roman M. Kuznetsov, Natalia L. Bochkareva, Alexey Kukharenko, Alexey V. Lyundup, Franco Tagliaro, Svetlana A. Appolonova
Publikováno v:
Pharmaceuticals, Vol 14, Iss 7, p 668 (2021)
The strong psychoactive effects of synthetic cannabinoids raise the need for the deeper studying of their neurometabolic effects. The pharmacokinetic properties of 5F-APINAC and its influence on metabolomics profiles associated with neurotransmission
Externí odkaz:
https://doaj.org/article/e670fa7c40154b3781590e1deecd1621
Autor:
Ksenia M. Shestakova, Natalia E. Moskaleva, Natalia V. Mesonzhnik, Alexey V. Kukharenko, Igor V. Serkov, Igor I. Lyubimov, Elena V. Fomina-Ageeva, Vladimir V. Bezuglov, Mikhail G. Akimov, Svetlana A. Appolonova
Publikováno v:
Molecules, Vol 25, Iss 24, p 5896 (2020)
Prostanit is a novel drug developed for the treatment of peripheral arterial diseases. It consists of a prostaglandin E1 (PGE1) moiety with two nitric oxide (NO) donor fragments, which provide a combined vasodilation effect on smooth muscles and vasc
Externí odkaz:
https://doaj.org/article/69472e20970247caa7915ac4d6983d84
Autor:
Olga I. Kiseleva, Yulia A. Romashova, Natalia E. Moskaleva, Natalia A. Petushkova, Nadezhda B. Teryaeva, Artem Yu. Belyaev, Andrey V. Lisitsa
Publikováno v:
Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)
Abstract BackgroundThe development of commercially available panels for human blood plasma screening via selected reaction monitoring (SRM) offers reliable, cost‐efficient and highly‐standardized discovery and validation of protein biomarkers. Ho
Externí odkaz:
https://doaj.org/article/61ccfea0ec5b4e709077b85a1212064f
Autor:
Natalia V. Mesonzhnik, Svetlana A. Appolonova, N V Pyatigorskaya, Kseniia M. Shestakova, Natalia E. Moskaleva
Publikováno v:
"Medical & pharmaceutical journal "Pulse". :43-50
Nitroproston is an innovation multitarget pharmaceutical based on natural prostaglandin and dinitroglycerol moety. The drug was developed for treatment of obstructive diseases in lungs including asthma and obstructive bronchitis. The goal of the pres
Autor:
Yuri N. Belenkov, Natalia E. Moskaleva, Alexey Kukharenko, Alex Brito, Ekaterina V. Larcova, Andrea Ariani, Svetlana A. Appolonova, Natalia L. Bochkareva, Michael R. La Frano, M V Kozhevnikova, Pavel A. Markin, E. V. Privalova, Ekaterina O. Korobkova
Publikováno v:
Clinica Chimica Acta. 507:250-256
The development of cardiovascular diseases (CVDs) is often asymptomatic. Identification of initial indicators of cardiometabolic disruption may assist in its early detection. The objective was to determine the relationships between plasma acylcarniti